Scarica l'app Stockscreener
78.60
3.39%
-2.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$81.36
Aprire:
$81.31
Volume 24 ore:
9.53M
Relative Volume:
1.31
Capitalizzazione di mercato:
$99.78B
Reddito:
$393.94B
Utile/perdita netta:
$428.00M
Rapporto P/E:
205.44
EPS:
0.3826
Flusso di cassa netto:
$6.29B
1 W Prestazione:
-2.12%
1M Prestazione:
+0.40%
6M Prestazione:
+23.20%
1 anno Prestazione:
+51.27%
Intervallo 1D:
$78.47
$81.56
Intervallo di 1 settimana:
$78.12
$81.56
Portata 52W:
$51.80
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
78.60 | 103.28B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
331.02 | 307.04B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
374.87 | 84.88B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
272.21 | 74.24B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
273.28 | 34.15B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
PBMs Seek Exit From Philly's Suit Over Opioid Crisis - Law360
CVS Health Corporation (CVS) Board Approves Quarterly Dividend As Cantor Fitzgerald and Bernstein Assert Bullishness - Insider Monkey
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
CVS Health offering MMR vaccine at Ohio pharmacy locations - WFMJ.com
CVS Ducks Antitrust But Not Biz Interference Claim At 5th Circ. - Law360
CVS Has Standing to Pursue Amitiza Antitrust Claims, Court Says - Bloomberg Law News
WNC & Associates, Freeport Housing Trust, Best Apartments, Inc. and CVS Health Break Ground on Varney Heights, a 42-Unit Senior Housing Community in Freeport, Maine - Yahoo Finance
CVS Health sets Feb. 10 earnings webcast on Q4 and 2025 financial results - Stock Titan
Manning & Napier Advisors LLC Sells 57,032 Shares of CVS Health Corporation $CVS - MarketBeat
CVS, Caremark Prevail in Appeal of Pharmacy Benefit Lawsuit - Bloomberg Law News
CVS Health Foundation Grants the American Diabetes Association $2.6 Million to Expand Maternal Diabetes Program Across Two Additional NYC Communities - Finviz
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm - GlobeNewswire Inc.
Earnings Preview: What To Expect From CVS Health's Report - Barchart.com
$2.6M diabetes grant backs healthier pregnancies in NYC communities - Stock Titan
Could CVS Health Corporation's (NYSE:CVS) Weak Financials Mean That The Market Could Correct Its Share Price? - Yahoo Finance
CVS Health Corp (NYSE:CVS) Shows Top Technical Rating and Superior Setup for Potential Breakout - Chartmill
CVS Health Foundation Grants $2.6M to Expand Maternal Diabetes Program - CVS Health
Risk Report: Can CVS Health Corporation generate free cash flowJuly 2025 Reactions & Accurate Entry/Exit Alerts - baoquankhu1.vn
Global Wealth Management Investment Advisory Inc. Takes $4.59 Million Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Canal Insurance CO - MarketBeat
CVS Health Corp.: How a Pharmacy Giant Is Rebuilding the Front Door to U.S. Healthcare - AD HOC NEWS
CVS plans to close another San Francisco retail store and pharmacy - The Business Journals
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance
CVS Health Corporation $CVS Stock Holdings Increased by TD Private Client Wealth LLC - MarketBeat
Polaris Capital Management LLC Increases Position in CVS Health Corporation $CVS - MarketBeat
Nordea Investment Management AB Sells 126,984 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Stock Position Boosted by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Tema Etfs LLC Makes New $1.56 Million Investment in CVS Health Corporation $CVS - MarketBeat
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says - Reuters
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report? - Finviz
Jim Cramer on CVS CEO: “Joyner’s Money” - Insider Monkey
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bernstein Raises PT on CVS Health (CVS) to $91, Reiterates 'Market Perform' Rating - Finviz
Bernstein Raises PT on CVS Health (CVS) to $91, Reiterates ‘Market Perform’ Rating - Insider Monkey
CVS Health Corporation $CVS Holdings Cut by New York State Teachers Retirement System - MarketBeat
Oliver Luxxe Assets LLC Takes $6.71 Million Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by SG Americas Securities LLC - MarketBeat
Jim Cramer Commented on These 13 Stocks From Different Market Sectors - Insider Monkey
Oregon Public Employees Retirement Fund Purchases 35,615 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) is a favorite amongst institutional investors who own 89% - Yahoo Finance
Aug Weekly: Will CVS Health Corporation stock outperform international peersJuly 2025 Snapshot & Low Drawdown Trading Techniques - Улправда
CVS Health Corp.: How a Pharmacy Giant Is Re?Engineering the Front Door to U.S. Healthcare - AD HOC NEWS
Jim Cramer Reveals How CVS Health Corporation (CVS) is "Saving a Lot of Money" - Finviz
Jim Cramer Reveals How CVS Health Corporation (CVS) is “Saving a Lot of Money” - Insider Monkey
Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill - Reuters
CVS will discuss 2025 results on a public call Feb. 11 at 8 a.m. ET online - Stock Titan
Why CVS Health Corporation stock is popular among millennialsQuarterly Market Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru
Cerity Partners LLC Has $40.45 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
US lawmakers seek testimony from five health insurers - Reuters
US Market Recap: How CVS Health Corporation stock reacts to monetary easingChart Signals & Consistent Return Investment Signals - ulpravda.ru
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):